S2M — S2Medical AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK10.47m
- SEK9.46m
- SEK14.91m
Annual income statement for S2Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 25.6 | 7.7 | 4.67 | 6.97 | 14.9 |
| Cost of Revenue | |||||
| Gross Profit | 10 | 7.1 | 5.17 | 5.04 | 14.1 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 40.7 | 27.5 | 32.4 | 22.2 | 9.12 |
| Operating Profit | -15.1 | -19.8 | -27.7 | -15.3 | 5.79 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -15.1 | -20.1 | -29.5 | -22.7 | 5.77 |
| Net Income After Taxes | -15.1 | -20.1 | -29.5 | -22.7 | 5.77 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -15.1 | -20.1 | -29.5 | -22.7 | 5.77 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -15.1 | -20.1 | -29.5 | -22.7 | 5.77 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.253 | -0.263 | -0.325 | -0.142 | 0.01 |
| Dividends per Share |